Trichomonasis is curable when treated. However there is increasing incidence of resistance to therapeutic drugs. Solanum torvum has several ethnomedicinal applications and therefore a potential source of antiparasitic drugs. The objective of this study was to assess the therapeutic potentials of extracts of fruits of 
INTRODUCTION
Trichomoniasis is a genitourinary tract, largely nonreported, sexually transmitted disease caused by the multiflagellated protozoan parasite, Trichomonas vaginalis. In males, infection. is restricted to the urethra and prostate and in females, to the lower part of the genital tract. the vagina, vulva urethra (Eckert, 2005) . The only known trichomonas host to date are humans and the parasite is transmitted from one person to the other mainly through sexual intercourse (Petrin et al., 1998) . Although very rare, transmission through means other than sexual contact involves contaminated douche nozzles, moist wash-clothes, specula or toilet seats (Petrin et al., 1998; Burch et al., 1959; Peterson and Drame, 2010) . Infection of newborn by the mother during vaginal delivery is also possible and has been reported in 2-17% of cases (Petrin et al., 1998) .
In about 70% of people infected with trichomoniasis, there are no signs or symptoms of the disease http://www.cdc.gov/std/Trichomonas/STDFactTrichomoniasis.htm). Although the disease is generally asymptomatic, especially in men in women in the first six months of infection, symptoms may include scanty vaginal secretion mixed with mucus, a copious discharge that is foamy, may be clear, white, yellowish or greenish with offensive odour (Cudmore et al., 2004) . Other symptoms in women are itching, burning, redness, or soreness of the genitals discomfort while urinating. In men, symptoms may include itching or irritation inside the penis, burning after urination or ejaculation, or some discharge from the penis (http://www.cdc.gov/std/Trichomonas/ STD FactTrichomoniasis.htm).
Although the disease does not kill, it is a serious public health problem largely because of associated complications and its implication as a predisposing factor for HIV infection these complications and associated hazards include: Development of prostate cancer, preterm delivery, prenatal morbidity, delivery of low-birth-weight, cervical cancer, sterility increased risk of infection with other sexually transmitted diseases such as gonorrhoea, chlamydiasis and yeast infections (http://en.wikipedia.org/wiki/Trichomoniasis downloaded on 16/07/2012).
The high prevalence rate of the disease also contributes to its being of very important public health problem. With a global incidence of over 180 million people infected annually (Weinstock et al., 2004) is no consensus figure for the prevalence of trichomoniasis in Nigeria but reports of prevalence rates of 9.7, 10.2, 11.1, 23.53, 24.7% up to 74.5% have been documented (Prevalence of trichomonas vaginalis in patients with vaginal discharge in Lagos, Nigeria (Ogunbanjo et al., 1989; Anosike et al., 1993; Woken, 2006; Ulogu et al., 2007) .
Chemotherapy is yet the main method of control although preventive measures of safe sex and avoidance of having multiple sex partners can significantly limit infection. Trichomoniasis is completely curable but the chemotherapeutic armoury is extremely inadequate as only either metronidazole or tinidazole is currently used for the treatment of the disease. This is unacceptable because of the increasing incidence of resistance to therapeutic drugs by infective agents.
Pants provide excellent sources for antiparasitic drugs and the use of herbal preparations for the treatment of trichomoniasis has been reported and such herbs include garlic, Echinacea, goldenseal, barberry, milk thistle, tea tree oil and Chinese gentian root (Long Dan Chao) tea (http://herbs.lovetoknow.com/ Natural_Cures_for_Trichomonas; http://www.ehow. com/how_542 7023_heal-trichomoniasis-herbs.html downloaded 18/07/2012). It is believed that these natural remedies act by boosting the immune system and subsequent clearance of the parasites. Antitrichomonal activity of several other plants have also been documented in the literature (Hakizamungu et al., 1992; Calzada et al., 2007; Desrivot et al., 2007; Fernandes et al., 2008; Ibikunle and Ogbadoyi, 2011a) .
The use of metronidazole and its derivatives for the treatment of trichomoniasis, apart from the resistance problem, is limited by the effects on the DNA (Narcisi and Sacor, 1996) Clearly, alternative curative therapies are needed, given the wide spread occurrence and impact of the disease.
Solanum torvum Solanaceae plants produce small perfectly spherical fruits and are commonly grown in the tropical regions of Nigeria. The fruits are used in some areas of the world as sauces, condiments, spices food flavorings (Burkill, 1985) .
The ethno medicinal applications includes treatment of arteries, naso-pharyngeal affections, veins, cutaneous, subcutaneous parasitic-infections, diarrhoea, dysentery, insanity, pain killer, gout, epilepsy, dropsy, swelling, oedema, stomach troubles, sedatives, diuretic tonic for liver and pulmonary troubles (Burkill,1985) . Antiviral and rodenticidal agents from extracts of Solanum torvum fruits have also been documented in the literature (Chah et al., 2000; Arthan et al., 2002; Muhammud et al., 2008) .
Methanolic extract of S. torvum is known to reduce blood pressure, vascular reactivity changes to catecholamines and reverse metabolic alterations induced by fructose (Muhammud et al., 2008) .
The isolated methyl caffeate (1) from the extract inhibited sucrase and maltase in rat intestinal. Also caffeoyl derivatives have sucrase-and maltaseinhibitory activities. Methyl caffeate moderate inhibitory action against α-glucosidase provides a prospect for antidiabetic usage of S. torvum fruit.
In an in vitro study of S. torvum against human pathogenic strains and animal clinical isolates, the water, methanolic and ethanol extracts were found effective against all bacterial strains with an inhibition comparable to that of commercial antibiotics (Takahashi et al., 2009; Chah et al., 2000) .
In this study, crude and partially purified extracts of S. torvum were screened for in vitro activity against Trichomonas gallinarum. We report here that crude extract of S. torvum and fractions thereof possess remarkable anti-trichomonas activity against T. gallinarum. fractions there of possess remarkable antitrichomonas activity against T. gallinarum.
MATERIALS AND METHODS

Materials:
Birds and eggs: Local pigeon Columba lavia Anth (Columbidea) and the raw chicken eggs were purchased from Central Market, Minna, Niger State, Nigeria. The parasites T. gallinarum were isolated from the throat of local Pigeon C. lavia as previously described. (Ibikunle and Ogbadoyi, 2011a) .
Plant material: Solanum torvum (Solanaceae) unripe fruits were collected in June 2009 from the shrubs at Iddo-Ekiti, Ekiti State, Nigeria and authenticated at Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria with herbarium number 14 Immediately after the collection, the unripe fruits were garbled to remove the unwanted parts and then air dried in the laboratory. They were then powdered and kept in polythene bags until needed.
Methods: Preparation of extracts:
The powdered plant material 100 g of S. torvum fruits was cold extracted in 250 cm 3 five times for six days with 100% methanol by maceration. The crude extracts were bulked and concentrated in-vacuo using a rotatory evaporator and coded STF. The weight and % dry weight yield of the crude methanolic extract were 7.03 g and 7.03%, respectively. Anti-trichomonal assay: The assay was done according to the method of Omisore et al. (2005) and Ibikunle et al. (2011b 1000, 500, 250, 125, 62.5, 144. 31.25, 15.625, 7 .812 and 3.906 µg/mL concentrations and each was assayed for anti-trichomonal activity. The same serial dilutions were prepared for the positive control using metronidazole as the standard drug. The inoculum (150 µL) was added into each well of the 96-well flat-bottom microwell plates and 50 µL of the test substance or metronidazole in its appropriate concentration was then added. The plates were thereafter incubated at 37°C and the cell growth was monitored at 24 and 48 h by counting their numbers with the microscope. For the negative control, 50 µL of overlay with DMSO was added to the 150 µL inoculum instead of the test substance (Narcisi and Sacor, 1996) . The tests were repeated three times (N = 6) for the test agents and the controls while the Lethal Doses (LD 50 153. and LD 90 ) were determined at 24 and 48 h using the Finney Probit analysis and Minitab14 computer statistical software (Finney, 1971) . (Table 3) . The values ranged from 37.86±2.35 µg/mL for sub fraction 3 to 87.14±1.38 µg/mL for sub fraction 4. The LC 90 were all above 100 µg/mL. At Table 4 : Anti-trichomonal Activity of VLC sub-fractions (STF21-28) from the partition fraction of Solanum torvum STF2 showing the LD50 and LD90 (µg/mL) at 24 and 48 h
Partitioning of crude methanolic extracts (STF):
RESULTS
The
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Fraction codes At 24 h, the chloroform VLC sub fractions all had remarkable activity except for sub fractions 1, 5 and 8 which had LC 50 values above 100 µg/mL (Table 4) .
The methanol VLC sub fractions 3, 4, 5 and 7 all had LC 50 below 100 µg/mL with only sub fraction 4 having LC 90 below 100 µg/mL at 24 and 48 h post treatment (Table 5) .
DISCUSSION
Analysis of data obtained clearly demonstrates the remarkable antitrichomonal activity of extracts of Solanum torvum with the aqueous partition fraction (STF 4 ) having significantly higher bioactivity than the standard drug metronidazole. With a much better bioactivity at 48 h post treatment than the standard drug, it may well be that this fraction has better metabolic stability and therefore cleared much slower than the standard drug. The better activity of the standard drug at 24 h post treatment is however worthy of note in order to adequately assess fast acting and faster metabolic clearance versus slow acting but slower metabolic clearance.
Impressed by the bioactivity of the petroleum ether, chloroform and methanol partition fractions, it was thought that further purification of the fractions using a combination of Vacuum Liquid Chromatography (VLC) and thin layer chromatography, the bioactivity may be significantly improved. It turned out that this was not necessarily so in all the cases. The petroleum ether VLC sub fraction 3 (STF 13 ) had an improved bioactivity with its LC 90 value at 48 h post treatment not significantly different from that of the standard drug. In fact the absolute value for STF 13 was slightly lower therefore, better than that of the standard drug. The methanol VLC sub fraction 4 (STF 34 ) also had an LC 90 value that was not significantly different from that of the standard drug though the absolute value for the standard drug was much lower than that of STF 34 . Taken together, these results clearly show the huge potential for the development of an effective antitrichomoniasis drug from Solanum torvum. The exciting aspect of all this is the bioactivity being found in aqueous and organic fractions, suggesting that the bioactive compounds are different and might be acting on different targets in the parasite. If this turns out to be the case, the prospects for the parasite developing resistance to any new drug that may be developed will be very low. This is a very important consideration in antiparasitic drug development generally. It is hoped that further studies on the bioactive fractions, particularly, the aqueous partition fraction will lead to the isolation of a pure compound with further improved bioactivity. Bioactive compound (s) so isolated can be standardized and packaged as herbal preparation for use in the treatment of trichomonal infections or serve as template (s) for chemical modifications in the production of efficacious synthetic drugs. These studies are currently on going in our laboratory.
CONCLUSION
It is concluded that extracts of the fruits of S. torvum contain bioactive antitrichomanal phytochemicals that form the basis for the development and production of drugs for the effective treatment of trichomonal infections.
